These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38780408)

  • 1. Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug.
    Ross CL; Lawer A; Sircombe KJ; Pletzer D; Gamble AB; Hook S
    J Med Chem; 2024 Jun; 67(11):9599-9612. PubMed ID: 38780408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hypoxia-activated antibacterial prodrug.
    Yeoh YQ; Horsley JR; Polyak SW; Abell AD
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127140. PubMed ID: 32247730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel nitroreductase enzyme-activated nitric oxide prodrugs to site-specifically kill bacteria.
    Hibbard HAJ; Reynolds MM
    Bioorg Chem; 2019 Dec; 93():103318. PubMed ID: 31586703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of existing antibiotics in the form of precursor prodrugs that can be subsequently activated by nitroreductases of the target pathogen.
    Çelik A; Yetiş G; Ay M; Güngör T
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4057-60. PubMed ID: 27390065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug.
    Evans LE; Krishna A; Ma Y; Webb TE; Marshall DC; Tooke CL; Spencer J; Clarke TB; Armstrong A; Edwards AM
    J Med Chem; 2019 May; 62(9):4411-4425. PubMed ID: 31009558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Antibacterial Activity Guided by Bacteria-Specific Nitroreductase Catalytic Activation to Produce Ciprofloxacin.
    Pardeshi KA; Kumar TA; Ravikumar G; Shukla M; Kaul G; Chopra S; Chakrapani H
    Bioconjug Chem; 2019 Mar; 30(3):751-759. PubMed ID: 30615427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorogenic H
    Xie Y; Huang H; Ismail I; Sun H; Yi L; Xi Z
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126627. PubMed ID: 31444083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.
    Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA
    J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate glycosidic activity in metallic implants for localized synthesis of antibacterial drugs.
    Ter Meer M; Dillion R; Nielsen SM; Walther R; Meyer RL; Daamen WF; van den Heuvel LP; van der Vliet JA; Lomme RMLM; Hoogeveen YL; Schultze Kool LJ; Schaffer JE; Zelikin AN
    Chem Commun (Camb); 2019 Jan; 55(4):443-446. PubMed ID: 30489589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.
    Firsov AA; Vostrov SN; Kononenko OV; Zinner SH; Portnoy YA
    Antimicrob Agents Chemother; 1999 Mar; 43(3):498-502. PubMed ID: 10049257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
    Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
    J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus.
    Oh SH; Park HS; Lee JH; Baek SY; Chae SE; Oh K; Cho YL; Kwak JH
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186032
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
    Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
    Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy.
    Chan-Hyams JVE; Copp JN; Smaill JB; Patterson AV; Ackerley DF
    Biochem Pharmacol; 2018 Dec; 158():192-200. PubMed ID: 30352235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of a halogenated phenazine-erythromycin conjugate prodrug for antibacterial applications.
    Yang H; Liu K; Jin S; Huigens Iii RW
    Org Biomol Chem; 2021 Feb; 19(7):1483-1487. PubMed ID: 33521803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
    Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
    J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enamide Prodrugs of Acetyl Phosphonate Deoxy-d-xylulose-5-phosphate Synthase Inhibitors as Potent Antibacterial Agents.
    Bartee D; Sanders S; Phillips PD; Harrison MJ; Koppisch AT; Freel Meyers CL
    ACS Infect Dis; 2019 Mar; 5(3):406-417. PubMed ID: 30614674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.